Heirloom Wealth Management Has $9.69 Million Stake in Intuitive Surgical, Inc. $ISRG

Heirloom Wealth Management grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3,700.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 17,100 shares of the medical equipment provider’s stock after buying an additional 16,650 shares during the quarter. Intuitive Surgical comprises 2.2% of Heirloom Wealth Management’s portfolio, making the stock its 17th biggest position. Heirloom Wealth Management’s holdings in Intuitive Surgical were worth $9,685,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of the business. Brighton Jones LLC boosted its stake in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares in the last quarter. Sivia Capital Partners LLC raised its holdings in shares of Intuitive Surgical by 3.8% in the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after buying an additional 34 shares during the last quarter. Schnieders Capital Management LLC. raised its holdings in shares of Intuitive Surgical by 38.0% in the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after buying an additional 268 shares during the last quarter. Level Four Advisory Services LLC lifted its position in Intuitive Surgical by 13.6% during the 2nd quarter. Level Four Advisory Services LLC now owns 975 shares of the medical equipment provider’s stock worth $530,000 after buying an additional 117 shares in the last quarter. Finally, Smith Moore & CO. bought a new stake in Intuitive Surgical during the 2nd quarter worth about $212,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

ISRG opened at $460.99 on Wednesday. The firm has a 50 day simple moving average of $491.53 and a 200 day simple moving average of $513.74. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The company has a market cap of $163.71 billion, a price-to-earnings ratio of 58.43, a price-to-earnings-growth ratio of 3.49 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same period last year, the firm earned $2.21 earnings per share. The business’s revenue for the quarter was up 18.8% on a year-over-year basis. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Royal Bank Of Canada boosted their target price on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 29th. The Goldman Sachs Group reiterated a “buy” rating and issued a $714.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 9th. Evercore lowered their target price on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a research note on Friday, January 23rd. Finally, Argus cut their price target on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $614.95.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analyst/technical optimism: Commentary noting ISRG is technically oversold and that Wall Street estimate revisions are tilting upward is supporting a near-term bounce and buy-the-dip demand. Down 10.1% in 4 Weeks, Here’s Why Intuitive Surgical (ISRG) Looks Ripe for a Turnaround
• Positive Sentiment: Fundamentals remain supportive: Intuitive posted an EPS and revenue beat in its latest quarter with healthy margins and double‑digit revenue growth year-over-year — this gives investors confidence that demand for robot-assisted procedures and consumables can reaccelerate. (See company reports and recent earnings commentary.)
• Neutral Sentiment: Market recap: Recent news pieces note ISRG rose but still lagged the broader market on the session, reflecting mixed investor appetite versus larger-cap growth peers. Intuitive Surgical, Inc. (ISRG) Rises But Trails Market: What Investors Should Know
• Neutral Sentiment: Sector/peer headlines may influence sentiment: Big moves in med‑tech peers (large drawdowns at some names and product launches at others) are creating rotation and headline-driven volatility that can impact ISRG. Examples include coverage of Boston Scientific’s selloff and Baxter’s new IV labeling system. Can Boston Scientific Stock Surge 40% From Here? Baxter International Unveils IV Verify to Enhance IV Labeling Accuracy
• Negative Sentiment: Technical and momentum concerns remain: ISRG has been through a recent pullback (50‑day moving average below the 200‑day) and a multi-week decline that could keep downside risk elevated if procedure volumes or guidance disappoint. Investors should watch upcoming volumes, guidance, and margin commentary closely.

Insider Buying and Selling

In other news, SVP Patricia L. Wadors sold 220 shares of the firm’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the sale, the executive vice president directly owned 409 shares of the company’s stock, valued at approximately $202,438.64. This trade represents a 50.72% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 32,943 shares of company stock worth $17,279,568 over the last 90 days. 0.60% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.